Moderna and Immatics Announce Strategic Multi-Platform Collaboration

Develop Innovative Oncology Therapeutics

13-Sep-2023 - Moderna, Inc. and Immatics N.V. announced a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need. This broad multi-platform collaboration will leverage the deep scientific expertise and core operational ...

Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands

03-Jun-2021 - Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Geleen (NL) ...

Lonza and Moderna Enter New Agreement to Double Drug Substance Production for COVID-19 Vaccine in Visp

New agreement for three further production lines at Lonza’s site in Visp, Switzerland

29-Apr-2021 - Lonza announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna. The expanded collaboration provides for the installation of three additional drug ...

Moderna Launches Third Venture Company Elpidera for Rare Diseases

Greg Licholai, M.D., hired as president to lead the venture to advance novel messenger RNA therapies

15-May-2015 - Moderna Therapeutics announced the launch of Elpidera LLC, a new Moderna venture focused exclusively on the advancement of mRNA-based medicines for the treatment of rare diseases. The third in a series of venture companies created by Moderna, Elpidera will be led by Dr. Greg Licholai, an industry ...

Moderna and Institut Pasteur Sign Strategic Research Collaboration

Research partnership will advance the development of mRNA vaccines and passive immunity therapies for infectious diseases

05-Feb-2015 - Moderna Therapeutics and the Institut Pasteur announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna's mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna. Valera ...

Moderna Launches New Venture Valera LLC for Infectious Diseases

12-Jan-2015 - Moderna Therapeutics announced the launch of Valera LLC, a new Moderna venture focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases. The vaccines work of Valera builds on a body of preclinical ...